Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02968212 |
|
Recruitment Status :
Recruiting
First Posted : November 18, 2016
Last Update Posted : March 27, 2024
|
Sponsor:
Oregon Health and Science University
Collaborators:
National Heart, Lung, and Blood Institute (NHLBI)
National Jewish Health
The University of Texas Health Science Center at Tyler
National Institute of Allergy and Infectious Diseases (NIAID)
University of Chicago
Temple University
University of South Florida
Information provided by (Responsible Party):
Kevin Winthrop, Oregon Health and Science University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | December 2024 |
| Estimated Study Completion Date : | April 2025 |